BioNxt Solutions Inc. (OTCMKTS:BNXTF – Get Free Report) saw a large drop in short interest in January. As of January 31st, there was short interest totalling 4,100 shares, a drop of 10.9% from the January 15th total of 4,600 shares. Based on an average daily volume of 2,700 shares, the short-interest ratio is currently 1.5 days.
BioNxt Solutions Stock Up 4.3 %
BNXTF stock opened at $0.33 on Tuesday. BioNxt Solutions has a one year low of $0.11 and a one year high of $0.49. The firm has a 50-day moving average of $0.27 and a two-hundred day moving average of $0.21.
BioNxt Solutions (OTCMKTS:BNXTF – Get Free Report) last posted its quarterly earnings results on Friday, November 29th. The company reported ($0.01) earnings per share (EPS) for the quarter.
BioNxt Solutions Company Profile
BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.
Featured Articles
- Five stocks we like better than BioNxt Solutions
- Short Selling: How to Short a Stock
- Airbnb’s Earnings: Sky High Results, Grounded Guidance?
- How to Most Effectively Use the MarketBeat Earnings Screener
- Kyndryl Soars on AI, Cybersecurity Growth—What’s Next?
- Airline Stocks – Top Airline Stocks to Buy Now
- Conflicting Signals: Tempus AI’s Stock Market Rally
Receive News & Ratings for BioNxt Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNxt Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
